Top news of the week: 21.07.2020.
#COVID19 #coronavirus #VaccinesWork #UnleashingInnovation #BioTech
Healthcare
Study provides first glimpse of efficacy of Oxford-AstraZeneca Covid-19 vaccine https://t.co/FvB73HdDG2
By me and @damiangarde
OpenStudies provide glimpse at efficacy of Covid-19 vaccines from Oxford-AstraZeneca and CanSino
The vaccine generated an immune response in a study of roughly 1,000 patients, and all of the side effects were deemed mild or moderate.
Millions could be vaccinated against COVID-19 as UK secures strong portfolio of promising vaccines
The UK has secured early access to 90 million doses of promising coronavirus vaccine candidates.
Biopharma Update on the Novel Coronavirus: July 17 https://t.co/sYJNybcxJC https://t.co/whIT00hv8B
OpenBiopharma Update on the Novel Coronavirus: July 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 17, 2020.
RT @NAR: Singapore state-owned investment company Temasek continues push into biotech companies.
https://t.co/2CIhFoF5aD
OpenSingapore's Temasek expands investment in biotech companies
Sovereign fund leads UK Glympse Bio's $46.7m fundraising
RT @JayJYKim90s: Sanofi Considers U.S. Biotech Targets Including Principia https://t.co/tVYQiu4CjB
OpenSanofi Considers U.S. Biotech Targets Including Principia
(Bloomberg) -- Sanofi is studying potential acquisitions of U.S. biotechnology companies including Principia Biopharma Inc. as it seeks innovative treatments for clinical areas including ...
BioSpace Movers & Shakers, July 17
Biopharma and life sciences companies bolster their leadership teams and board with these Movers & Shakers.
Biopharma Update on the Novel Coronavirus: July 15 https://t.co/0fAKrFwEQm https://t.co/tWkZpHPTN1
OpenBiopharma Update on the Novel Coronavirus: July 15
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 15, 2020.
Patent Prosecution Tool Kit: Summary of Subject Matter Eligibility: Biotech/Pharma Inventions #BioTech via https://t.co/2sI0UxJbpn https://t.co/NEQFfTs0lG
OpenPatent Prosecution Tool Kit: Summary of Subject Matter Eligibility: Biotech/Pharma Inventions
It has nearly been ten years since the Supreme Court’s landmark Mayo v. Prometheus (132 S.Ct. 1289 (2012)) decision, in which the Court established a...